Report Detail
Global Antacids Market Insights, Forecast to 2025
- RnM2708103 |
- 06 May, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
The global Antacids market is valued at 6120 million US$ in 2018 and will reach 6460 million US$ by the end of 2025, growing at a CAGR of 0.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antacids market based on company, product type, end user and key regions.
This report studies the global market size of Antacids in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antacids in these regions.
This research report categorizes the global Antacids market by top players/brands, region, type and end user. This report also studies the global Antacids market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
Market size by Product
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Market size by End User
Rx Drug
OTC Drug
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antacids market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antacids market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antacids companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antacids submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antacids are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antacids market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antacids Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antacids Market Size Growth Rate by Product
- 1.4.2 Proton Pump Inhibitor
- 1.4.3 H2 Antagonist
- 1.4.4 Acid Neutralizers
- 1.5 Market by End User
- 1.5.1 Global Antacids Market Size Growth Rate by End User
- 1.5.2 Rx Drug
- 1.5.3 OTC Drug
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antacids Market Size
- 2.1.1 Global Antacids Revenue 2014-2025
- 2.1.2 Global Antacids Sales 2014-2025
- 2.2 Antacids Growth Rate by Regions
- 2.2.1 Global Antacids Sales by Regions
- 2.2.2 Global Antacids Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antacids Sales by Manufacturers
- 3.1.1 Antacids Sales by Manufacturers
- 3.1.2 Antacids Sales Market Share by Manufacturers
- 3.1.3 Global Antacids Market Concentration Ratio (CR5 and HHI)
- 3.2 Antacids Revenue by Manufacturers
- 3.2.1 Antacids Revenue by Manufacturers (2014-2019)
- 3.2.2 Antacids Revenue Share by Manufacturers (2014-2019)
- 3.3 Antacids Price by Manufacturers
- 3.4 Antacids Manufacturing Base Distribution, Product Types
- 3.4.1 Antacids Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antacids Product Type
- 3.4.3 Date of International Manufacturers Enter into Antacids Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antacids Sales by Product
- 4.2 Global Antacids Revenue by Product
- 4.3 Antacids Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antacids Breakdown Data by End User
6 North America
- 6.1 North America Antacids by Countries
- 6.1.1 North America Antacids Sales by Countries
- 6.1.2 North America Antacids Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antacids by Product
- 6.3 North America Antacids by End User
7 Europe
- 7.1 Europe Antacids by Countries
- 7.1.1 Europe Antacids Sales by Countries
- 7.1.2 Europe Antacids Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antacids by Product
- 7.3 Europe Antacids by End User
8 Asia Pacific
- 8.1 Asia Pacific Antacids by Countries
- 8.1.1 Asia Pacific Antacids Sales by Countries
- 8.1.2 Asia Pacific Antacids Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antacids by Product
- 8.3 Asia Pacific Antacids by End User
9 Central & South America
- 9.1 Central & South America Antacids by Countries
- 9.1.1 Central & South America Antacids Sales by Countries
- 9.1.2 Central & South America Antacids Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antacids by Product
- 9.3 Central & South America Antacids by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antacids by Countries
- 10.1.1 Middle East and Africa Antacids Sales by Countries
- 10.1.2 Middle East and Africa Antacids Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antacids by Product
- 10.3 Middle East and Africa Antacids by End User
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Antacids Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 Takeda Pharmaceutical
- 11.2.1 Takeda Pharmaceutical Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Takeda Pharmaceutical Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Takeda Pharmaceutical Antacids Products Offered
- 11.2.5 Takeda Pharmaceutical Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Antacids Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Reckitt Benckiser
- 11.4.1 Reckitt Benckiser Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Reckitt Benckiser Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Reckitt Benckiser Antacids Products Offered
- 11.4.5 Reckitt Benckiser Recent Development
- 11.5 Bayer
- 11.5.1 Bayer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer Antacids Products Offered
- 11.5.5 Bayer Recent Development
- 11.6 Procter＆Gamble
- 11.6.1 Procter＆Gamble Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Procter＆Gamble Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Procter＆Gamble Antacids Products Offered
- 11.6.5 Procter＆Gamble Recent Development
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline Antacids Products Offered
- 11.7.5 GlaxoSmithKline Recent Development
- 11.8 Johnson＆Johnson
- 11.8.1 Johnson＆Johnson Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Johnson＆Johnson Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Johnson＆Johnson Antacids Products Offered
- 11.8.5 Johnson＆Johnson Recent Development
- 11.9 CONBA
- 11.9.1 CONBA Company Details
- 11.9.2 Company Business Overview
- 11.9.3 CONBA Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 CONBA Antacids Products Offered
- 11.9.5 CONBA Recent Development
- 11.10 Xiuzheng Pharma
- 11.10.1 Xiuzheng Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Xiuzheng Pharma Antacids Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Xiuzheng Pharma Antacids Products Offered
- 11.10.5 Xiuzheng Pharma Recent Development
- 11.11 Sanofi
- 11.12 Bausch Health
- 11.13 CR SANJIU
- 11.14 Reddy's Laboratories
12 Future Forecast
- 12.1 Antacids Market Forecast by Regions
- 12.1.1 Global Antacids Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antacids Revenue Forecast by Regions 2019-2025
- 12.2 Antacids Market Forecast by Product
- 12.2.1 Global Antacids Sales Forecast by Product 2019-2025
- 12.2.2 Global Antacids Revenue Forecast by Product 2019-2025
- 12.3 Antacids Market Forecast by End User
- 12.4 North America Antacids Forecast
- 12.5 Europe Antacids Forecast
- 12.6 Asia Pacific Antacids Forecast
- 12.7 Central & South America Antacids Forecast
- 12.8 Middle East and Africa Antacids Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antacids Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antacids . Industry analysis & Market Report on Antacids is a syndicated market report, published as Global Antacids Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antacids market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
